DONATE

Sightsavers researcher commended for innovative NTD project

September 2021
Kareen Atekem is shown in a yellow Sightsavers top standing outside next to a Sightsavers vehicle.
Kareen Atekem was selected as a finalist in the NTD Innovation Prize competition. Photo © Sightsavers/Dominique Catton

A researcher from Sightsavers has been recognised for her work on a new project to control and eliminate two neglected tropical diseases (NTDs).

NTD research coordinator Kareen Atekem was selected as a finalist in the NTD Innovation Prize competition. Along with her fellow finalists, she was given the opportunity to present about her project at the NTD NGO Network (NNN) conference on 7-9 September.

Her project involves developing a new trap for ‘Chrysops’ flies that spread loiasis, a parasitic disease caused by the loa loa worm. This disease poses a major barrier to the elimination of river blindness, one of the most common infectious causes of blindness in the world.

If someone is suffering from loiasis and takes medication to treat river blindness (also known as onchocerciasis), they could have a serious, life-threatening reaction. This means that it is not possible to treat for onchocerciasis in areas where loiasis is present.

Kareen says: “The impact of this research is profound as it will allow more than 14 million people in Central Africa who are excluded from onchocerciasis treatment to receive the drugs safely.

“If successful, our innovative trap will also allow us to monitor ‘Chrysops’ populations, and eventually control the spread of these biting flies. This could reduce the risk of loiasis for whole communities and regions.”

The NTD Innovation Prize was launched in 2019 by American Leprosy Missions to support innovators with creative ideas to solve some of the most challenging issues posed by NTDs across the globe. The prize is awarded each year during the NNN conference.

Sightsavers led a number of workshops at this year’s conference, exploring topics such as how to make sure that NTD treatment programmes are more responsive to community feedback, and how to ensure that these programmes are accessible for people with disabilities.

In future, Kareen and her colleagues will seek to implement the project in areas of Cameroon known to have large ‘Chrysops’ populations, where there is a high prevalence of loiasis, and where this is co-endemic with river blindness.

You can find out more by watching the video below, where Kareen explains more about her project.

Participants at a blood collection training session.

Our research

Sightsavers supports research in eye health, neglected tropical diseases, education and social inclusion. High-quality research is critical to help us to deliver our strategy and programmes successfully.

About our research

Read all our latest news stories

News from Sightsavers
A community drug distributor hands an elderly man medication to treat trachoma.
sightsavers_news

WHO report reveals millions no longer at risk from trachoma

The number of people at risk from trachoma has fallen by more than 12 million in a single year, according to a new report by the World Health Organization.

July 2024
Health worker Adesugba checks some medication in the clinic. She's surrounded by charts on the walls and paperwork on the tables.
sightsavers_news

Sightsavers and RSTMH extend research partnership

The organisations will publish two further collections of research papers in the journal International Health, focusing on river blindness and general research work.

May 2024
Arthur in the classroom, smiling while wearing his new glasses.
sightsavers_news

Sightsavers joins WHO initiative to improve access to spectacles

SPECS 2030 aims to tackle the world’s biggest cause of visual impairment by improving global access to eye care.

May 2024

Learn about our work to save sight